Day: August 2, 2021

Revenues up 20% with 20% EBITDA Margin BOULDER, Colo., Aug. 02, 2021 (GLOBE NEWSWIRE) — Gaia, Inc. (NASDAQ: GAIA), a conscious media and community company, reported financial results for the second quarter ended June 30, 2021. Highlights20% increase in revenues from the year-ago quarter Fourth sequential quarter of positive earnings and cash flow Improved EBITDA margin to 20%“The second quarter of 2021 represented another solid quarter of execution on our plan to generate net income and cash flows while driving revenue and member growth,” said Paul Tarell, Gaia’s CFO. “We are looking forward to the second half of the year, when our event lineup at GaiaSphere will be in full swing, which will allow us to promote our $299 premium subscription tier to current and prospective members.” Second Quarter 2021 Financial Results Revenues...

Brings more than 24 years of finance, accounting experience at MediaKind, Imagine Communications, GENBAND, McAfee and EY to role PLANO, Texas, Aug. 02, 2021 (GLOBE NEWSWIRE) — DZS (NASDAQ: DZSI), a global leader in optical and packet-based mobile transport, broadband connectivity, and software defined networking solutions, today announced the appointment of Misty Kawecki as Chief Financial Officer, effective immediately. Ms. Kawecki brings over 24 years of progressive finance and accounting experience at Big 4 accounting firms and public, private and private equity-owned companies to the role and will serve as a strategic advisor to CEO Charlie Vogt and the Board of Directors. She succeeds Tom Cancro, who served as CFO since 2019. “On behalf of the Board and management team, I want to thank Tom for his many contributions to DZS,...

Second quarter 2021 total revenue of $87.0 million including Crysvita1 revenue to Ultragenyx of $44.7 million 2021 Crysvita revenue in Ultragenyx territories1 guidance of $180 million to $190 million reaffirmed Strong Dojolvi launch continues with approximately 220 patients on reimbursed commercial therapy in the United States Phase 1/2 study of GTX-102 for the treatment of Angelman syndrome to begin enrolling patients in Canada and the U.K.; U.S. pending protocol revisions NOVATO, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today reported its financial results for the second quarter 2021 and reaffirmed its financial guidance for 2021. “In the...

MANCHESTER, NH , Aug. 02, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Minim, Inc. (NASDAQ: MINM) (the “Company”) today announced the closing of an underwritten public offering of 10,000,000 shares of the Company’s common stock at a public offering price of $2.50 per share for aggregate gross proceeds of approximately $22.7 million after deducting underwriting discounts, commissions, and other offering expenses. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares at the public offering price less the underwriting discounts and commissions. The Company intends to use the net proceeds it receives from the offering for general corporate and working capital purposes, which may include inventory optimization, development and marketing of new product offerings and...

NEW YORK, Aug. 02, 2021 (GLOBE NEWSWIRE) — StoneX Group Inc. (NASDAQ: SNEX) today announced that it will release its fiscal 2021 third quarter results after the market close on Monday, August 9, 2021. Management will host a conference call on Tuesday, August 10, 2021 at 9:00 a.m. Eastern time to review the Company’s 2021 fiscal third quarter results. A live web cast of the conference call as well as additional information to review during the call will be made available in PDF form at https://www.stonex.com. Participants can also access the call by dialing 1-844-466-4112 (within the United States and Canada), or 1-408-337-0136 (international callers) approximately ten minutes prior to the start time. A replay of the call will be available at https://www.stonex.com approximately two hours after the call has ended and will...

GALVESTON, Texas, Aug. 02, 2021 (GLOBE NEWSWIRE) — American National Group, Inc. (NASDAQ: ANAT) and subsidiaries (collectively, the “Company”) announced net income for the second quarter of 2021 of $228.0 million or $8.48 per diluted share, compared to net income of $210.5 million or $7.83 per diluted share for the same period in 2020. Net income for the second quarter of 2021 increased $17.5 million primarily due to:improved earnings in our property and casualty segment and annuity segment; an increase in net realized investment earnings; and a decline in net gains on equity securities.Adjusted net operating income for the second quarter of 2021 was $50.4 million or $1.87 per diluted share compared to $17.0 million or $0.63 per diluted share for the same period in 2020. This increase reflects improved earnings in our property...

2 August 2021 Disclosure of trading in own shares under a share buyback programme Period : From 23 July to 26 July 2021 Issuer’s registered name: Ipsos Issuer’s Identification code: 9695002OY2X35E9X8W87 Financial instrument reference: Ordinary shares – ISIN code FR0000073298 Reporting of transactions in aggregated form (per day and per trading venue)Issuer name Issuer code Transaction date ISIN code Daily total volume (in number of shares) Daily weighted average price of shares acquired Platform  Issuer LEI    ISIN code (ISO 6166)     MIC code (ISO 10383)IPSOS 9695002OY2X35E9X8W87 23-Jul-21 FR0000073298 9 000 38,3639 XPARIPSOS 9695002OY2X35E9X8W87 23-Jul-21 FR0000073298 5 700 38,4027 DXEIPSOS 9695002OY2X35E9X8W87 23-Jul-21 FR0000073298 1 350 38,4382 TQEIPSOS 9695002OY2X35E9X8W87 23-Jul-21 FR0000073298 1 670 38,4292 AQEIPSOS 9695002OY2X35E9X8W87 26-Jul-21 FR0000073298 14...